Stephen Doggett, MD
Radiation Oncology · Newport Beach, CANPI 1982675021
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,700 of the $33,004 with a category attached, or 65.7%. Elekta, Inc. accounts for 88.0% of it on its own, with 38 other manufacturers making up the rest. 2025 is the largest year on record at $29,125, more than ten times the $398 reported in 2019. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $320.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$29K
- Isoray, Inc$2K
- Johnson & Johnson$435
- Amgen$144
- AstraZeneca$105
- Karyopharm Therapeutics Inc.$93
- plus $1K from 33 others
Across 4 payments — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Theragenics Corporation$20K
What the payments were for
- Consulting fees$21,70066%
- Travel & lodging$8,39925%
- Food & beverage$2,9059%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 8 | $29,036 |
| Isoray, Inc | 14 | $1,980 |
| Johnson & Johnson(2 entities) | 13 | $435 |
| Amgen | 6 | $144 |
| AstraZeneca(2 entities) | 5 | $105 |
| Karyopharm Therapeutics Inc. | 2 | $93 |
| Bayer | 4 | $91 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $84 |
| Lilly USA, LLC | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Sanofi | 3 | $64 |
| Boston Scientific | 4 | $58 |
| Seagen Inc. | 2 | $55 |
| Siemens Medical Solutions USA, Inc. | 1 | $48 |
| Sobi, Inc | 2 | $47 |
| Puma Biotechnology, Inc. | 2 | $46 |
| Incyte Corporation | 2 | $41 |
| Octapharma USA, Inc. | 2 | $40 |
| Novartis | 2 | $39 |
| Teleflex LLC | 1 | $35 |
| EMD Serono, Inc. | 2 | $31 |
| Blueprint Medicines Corporation | 1 | $28 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Dova Pharmaceuticals | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| GSK | 1 | $24 |
| Global Blood Therapeutics, Inc. | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Pfizer | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $15 |
| GE HealthCare | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELEKTA MEDICAL LINEAR ACCELERATOR$18,170
- FLEXITRON HDR$10,807
- Brachytherapy Source$1,760
- Monarch Platform$107
How this compares
$33,004 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 29 | $154 |
| Tamsulosin Hcl | 12 | $149 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Newport Beach
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.